|
|
|
|
| LEADER |
02284nam a2200289 u 4500 |
| 001 |
EB000943162 |
| 003 |
EBX01000000000000000736752 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 020 |
|
|
|a 9781854334688
|
| 245 |
0 |
0 |
|a Drug misuse
|h Elektronische Ressource
|b psychosocial interventions
|c National Collaborating Centre for Mental Health (UK) ; commissioned by the National Institute for Health & Clinical Excellence
|
| 260 |
|
|
|a Leicester
|b British Psychological Society
|c 2008, c2008
|
| 300 |
|
|
|a PDF file (338 p.)
|b ill
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a United Kingdom
|
| 653 |
|
|
|a Substance-Related Disorders / therapy
|
| 653 |
|
|
|a Crisis Intervention
|
| 710 |
2 |
|
|a National Collaborating Centre for Mental Health (Great Britain)
|
| 710 |
2 |
|
|a British Psychological Society
|
| 710 |
2 |
|
|a Royal College of Psychiatrists
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a NICE clinical guidelines
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK53227
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a This guideline has been developed to advise on psychosocial interventions for drug misuse. The guideline recommendations have been developed by a multidisciplinary team of healthcare professionals, service users, a carer and guideline methodologists after careful consideration of the best available evidence. It is intended that the guideline will be useful to clinicians and service commissioners in providing and planning high-quality care for people who misuse drugs while also emphasising the importance of the experience of care for people who misuse drugs and their carers. Although the evidence base is rapidly expanding, there are a number of major gaps, and future revisions of this guideline will incorporate new scientific evidence as it develops. The guideline makes a number of research recommendations specifically to address gaps in the evidence base. In the meantime, it is hoped that the guideline will assist clinicians, people who misuse drugs and their carers by identifying the merits of particular treatment approaches where the evidence from research and clinical experience exists
|